Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CN-105 in Acute Supratentorial Intracerebral Hemorrhage
NCT03711903Phase 2Completed
- Sponsor
- National Neuroscience Institute
- Start
- Mar 2019
- Primary completion
- Jun 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CN-105 in intracerebral hemorrhage (ICH), sponsored by National Neuroscience Institute. Started Mar 2019; status: completed.
02
Drugs
CN-105
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03711903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03711903.